Stealth BioTherapeutics has been granted a patent for methods to generate specific peptides, including D-Arg-2’6′-Dmt-Lys-Phe-NH2, and their pharmaceutically acceptable salts. The patent also claims the compound Boc-D-Arg-DMT-OBn or its salts. GlobalData’s report on Stealth BioTherapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Stealth BioTherapeutics, was a key innovation area identified from patents. Stealth BioTherapeutics's grant share as of June 2024 was 22%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12037414B2 pertains to a specific compound identified as Boc-D-Arg-DMT-OBn, along with its salts. This compound is characterized by its unique chemical structure, which includes a Boc (tert-butyloxycarbonyl) protecting group, a D-Arg (D-arginine) amino acid, a DMT (dimethyltryptamine) moiety, and an O-benzyl (OBn) group. The inclusion of these functional groups suggests potential applications in fields such as pharmaceuticals, where modifications to amino acids can influence biological activity and therapeutic efficacy.
The patent claims the compound itself, as well as its salts, indicating a focus on both the base compound and its derivatives. Salts of compounds are often important in drug formulation, as they can enhance solubility and stability, which are critical factors in the development of effective therapeutic agents. The specificity of the claim to this particular compound suggests that it may possess unique properties or advantages that warrant patent protection, potentially paving the way for further research and development in related applications.
To know more about GlobalData’s detailed insights on Stealth BioTherapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
